Carelon Medical Benefits Management · Clinical Guideline · CARELON-cell-free-dna-testing-liquid-biopsy-for-the-management-of-cancer-2024-11-17-updated-2025-10-01-2
Source checked May 8, 2026 · Open the payer’s source
Summary of the payer’s published policy. Not a coverage determination — confirm with Carelon Medical Benefits Management before submitting.
Carelon Medical Benefits Management has replaced or withdrawn this version, and Backwork could not match it to a current one. The payer’s current policies are listed on its page.